A Medtech Exec, Pharma Exec and Venture Capitalist Walk Onto a Stage and Talk Digital Health

Posted by Pete Masloski on January 10, 2019

Vijesh Unnikrishnan co-wrote this article with Pete Masloski

It’s not often that you get medtech, pharma and venture capital executives to sit on the same panel and participate with enthusiasm and excitement—unless the topic is digital health, where the cross-pollination of ideas and solutions across industry players is becoming more of a norm than an exception. At ZS’s recent Digital and Connected Health Summit, we were fortunate to host a panel of experts who engaged us in a lively discussion: Andy Atwell, executive director of new business development at Omron; Pankaj Dubey, senior director, U.S. commercial, at Abbvie; Divya Varshney, digital health lead at Baxter; and Megan Zweig, director of research at Rock Health. The panelists shared their excitement and optimism, and some examples of how they see life sciences


>
Read More

Winning the Medtech Vs. Tech Battle: Five Lessons Learned From Tech’s Success

Posted by Raluca Cenusa on December 6, 2018

Tech companies are beating medtech companies at their own game. New tech players are entering the digital health space in droves, and digital health investment is at an all-time high.


>
Read More

Winning the Medtech Vs. Tech Battle: Five Ways To Keep Tech Competitors at Bay

Posted by Raluca Cenusa on December 4, 2018

When it comes to innovation, the rise of consumer technology giants entering the healthcare space, and interrupting the traditional ecosystem in which medtech device manufacturers, clinicians and providers currently exist, can be seen as "Goliath versus Goliath" matchups between large companies looking to maintain or capture opportunities.


>
Read More